PDC and bacterial infectious disease: Therefore, our data suggests that there is an increased activation of pDC due to SARS-CoV-2 infection leading to a robust type I IFN-dependent immunity against secondary infection (i.e., bacterial infection) that may further exacerbate the cytokine storm leading to adverse disease outcomes in aged patients (80).